secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001104659-25-089562
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics appoints Jason D. Sawyer as Interim CEO under consulting agreement at $12,500/month
--------------------------------------------------------------------------------

- Jason D. Sawyer appointed Interim CEO via consulting agreement with Access Alternative Group S.A., effective Sept 4, 2025.
- Compensation set at $12,500 per month; agreement renewable month-to-month at Company's discretion.
- Company to indemnify Sawyer as CEO to fullest extent under Delaware law; D&O insurance maintained.
- Prior interim CEO appointment disclosed Sept 9; formal consulting agreement entered Sept 8.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925089562/0001104659-25-089562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925089562/tm2525441d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-089562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer